The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis

Background/Aims: The main purpose of the present study was to determine the effect of peritoneal charge barrier dysfunction on hypoalbuminemia during CAPD. Methods: We measured the association of dialysis dose, peritoneal equilibration test (PET) results (ratio of dialysate and plasma creatinine), a...

Full description

Bibliographic Details
Main Authors: Guo-Qing Yu, Jian Chen, Jun-Xia Li
Format: Article
Language:English
Published: Karger Publishers 2013-07-01
Series:Kidney & Blood Pressure Research
Subjects:
Online Access:http://www.karger.com/Article/FullText/350150
_version_ 1819016116348911616
author Guo-Qing Yu
Jian Chen
Jun-Xia Li
author_facet Guo-Qing Yu
Jian Chen
Jun-Xia Li
author_sort Guo-Qing Yu
collection DOAJ
description Background/Aims: The main purpose of the present study was to determine the effect of peritoneal charge barrier dysfunction on hypoalbuminemia during CAPD. Methods: We measured the association of dialysis dose, peritoneal equilibration test (PET) results (ratio of dialysate and plasma creatinine), and peritoneal charge barrier index (ratio of pancreatic and salivary α-amylase clearance) on protein loss in 33 patients on maintenance CAPD. All patients were from a single institution and were diagnosed with chronic nephritis (n = 18 cases), diabetic nephropathy (n = 8), hypertension (n = 5), and hepatitis B virus-associated glomerulonephritis (n = 2). Results: The mean (± SD) dialysate protein loss was 4.04 g (± 1.97) per day. Protein loss was positively correlated with dialysis dose (r = 0.438, p = 0.01) but was not significantly correlated with PET results. The mean (± SD) peritoneal charge barrier index was 6.12 (± 21.20) and was inversely correlated with protein loss into the peritoneal dialysate (r = -0.532, p Conclusions: Taken together, our study of CAPD patients indicates that protein loss into the peritoneal dialysate increases with peritoneal dialysis dose and with disruption of the peritoneal charge barrier.
first_indexed 2024-12-21T02:42:31Z
format Article
id doaj.art-cf30ec99f7b34f18a1eae3540dd6ec9d
institution Directory Open Access Journal
issn 1420-4096
1423-0143
language English
last_indexed 2024-12-21T02:42:31Z
publishDate 2013-07-01
publisher Karger Publishers
record_format Article
series Kidney & Blood Pressure Research
spelling doaj.art-cf30ec99f7b34f18a1eae3540dd6ec9d2022-12-21T19:18:39ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432013-07-01374-525225810.1159/000350150350150The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal DialysisGuo-Qing YuJian ChenJun-Xia LiBackground/Aims: The main purpose of the present study was to determine the effect of peritoneal charge barrier dysfunction on hypoalbuminemia during CAPD. Methods: We measured the association of dialysis dose, peritoneal equilibration test (PET) results (ratio of dialysate and plasma creatinine), and peritoneal charge barrier index (ratio of pancreatic and salivary α-amylase clearance) on protein loss in 33 patients on maintenance CAPD. All patients were from a single institution and were diagnosed with chronic nephritis (n = 18 cases), diabetic nephropathy (n = 8), hypertension (n = 5), and hepatitis B virus-associated glomerulonephritis (n = 2). Results: The mean (± SD) dialysate protein loss was 4.04 g (± 1.97) per day. Protein loss was positively correlated with dialysis dose (r = 0.438, p = 0.01) but was not significantly correlated with PET results. The mean (± SD) peritoneal charge barrier index was 6.12 (± 21.20) and was inversely correlated with protein loss into the peritoneal dialysate (r = -0.532, p Conclusions: Taken together, our study of CAPD patients indicates that protein loss into the peritoneal dialysate increases with peritoneal dialysis dose and with disruption of the peritoneal charge barrier.http://www.karger.com/Article/FullText/350150AmylaseCharge barrierContinuous ambulatory peritoneal dialysisHypoalbuminemiaProtein Malnutrition
spellingShingle Guo-Qing Yu
Jian Chen
Jun-Xia Li
The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis
Kidney & Blood Pressure Research
Amylase
Charge barrier
Continuous ambulatory peritoneal dialysis
Hypoalbuminemia
Protein Malnutrition
title The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis
title_full The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis
title_fullStr The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis
title_full_unstemmed The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis
title_short The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis
title_sort association between peritoneal charge barrier dysfunction and protein lost during continuous ambulatory peritoneal dialysis
topic Amylase
Charge barrier
Continuous ambulatory peritoneal dialysis
Hypoalbuminemia
Protein Malnutrition
url http://www.karger.com/Article/FullText/350150
work_keys_str_mv AT guoqingyu theassociationbetweenperitonealchargebarrierdysfunctionandproteinlostduringcontinuousambulatoryperitonealdialysis
AT jianchen theassociationbetweenperitonealchargebarrierdysfunctionandproteinlostduringcontinuousambulatoryperitonealdialysis
AT junxiali theassociationbetweenperitonealchargebarrierdysfunctionandproteinlostduringcontinuousambulatoryperitonealdialysis
AT guoqingyu associationbetweenperitonealchargebarrierdysfunctionandproteinlostduringcontinuousambulatoryperitonealdialysis
AT jianchen associationbetweenperitonealchargebarrierdysfunctionandproteinlostduringcontinuousambulatoryperitonealdialysis
AT junxiali associationbetweenperitonealchargebarrierdysfunctionandproteinlostduringcontinuousambulatoryperitonealdialysis